Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:17 PM
Ignite Modification Date:
2025-12-24 @ 5:17 PM
NCT ID:
NCT00428350
Eligibility Criteria:
Inclusion Criteria:
* Provision of written informed consent for study participation before initiation of any study related procedures, signed by the patient's legal guardian
* Female and/or male, aged between 18 and 60 years (inclusive)
* Is hospitalised in a psychiatric unit with an acute episode of schizophrenia defined by CCMD-3 criteria as one of the following: \[20.1\] paranoid schizophrenia, \[20.2\] hebephrenic schizophrenia, \[20.3\] catatonic schizophrenia, \[20.5\] undifferentiated schizophrenia
Exclusion Criteria:
* CCMD-3 diagnosis of mental retardation
* Psychosis judged to be the direct physiological effect of an abused medication or substance
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00428350
Study Brief:
Protocol Section:
NCT00428350